OasisLMS

In this webinar, specialists will delve into the recent changes to the Guideline for Diagnosing and Managing Atrial Fibrillation. Our goal is to enhance your comprehension of how to effectively use anticoagulants and aspirin in treating patients with cardiovascular conditions, focusing especially on those with nonvalvular atrial fibrillation (NVAF). We'll cover issues like "clinical inertia" and its potential effects on patient results, alongside the proper care for individuals with NVAF. 

Participation and Successful Completion
Successful completion of this CE activity includes the following:

1. Register and view the course online.
2. View the content in its entirety.
3. Complete a post-test with a minimum score of 100%.
4. Complete a survey of your learning experience.
5. Claim your CE Certificate.

Hardware/Software Requirements
The most recent versions of Google Chrome, Microsoft Edge, Firefox, and Safari are supported. The compatible operating systems are Windows 10 or above and macOS 13 or above. Please note that Internet Explorer is no longer supported.

Target Audience
Physicians, Physician Assistants, Nurses, Nurse Practitioners, Pharmacists

Description

In this webinar, specialists will delve into the recent changes to the Guideline for Diagnosing and Managing Atrial Fibrillation. Our goal is to enhance your comprehension of how to effectively use anticoagulants and aspirin in treating patients with cardiovascular conditions, focusing especially on those with nonvalvular atrial fibrillation (NVAF). We'll cover issues like "clinical inertia" and its potential effects on patient results, alongside the proper care for individuals with NVAF.

Learning Objectives 
At the completion of this course, the learner will be able to:

• Identify changes in the new Guideline for Diagnosing and Managing Atrial Fibrillation.
• Discuss the current evidence for initiating anticoagulation in patients with NVAF with emphasis on stroke prevention. Explore the factors influencing the choice of anticoagulant and address common challenges in managing anticoagulation therapy for NVAF.
• Examine the prevalence of AF in the elderly population, morbidly obese, and patients with CKD and the challenges it poses in regards to anticoagulation therapy.
• Define alternatives to anticoagulation in patients who have contraindications to anticoagulant therapy and who are at increased thromboembolic risk.
• Describe the evidence-based, guideline-directed lifestyle and risk factor modification that patients should receive for primary and secondary prevention of atrial fibrillation.

Estimated Time to Complete the Educational Activity
65 minutes

 

Norma Keller, MD
Chief of Cardiology, HHC Bellevue Hospital Center
Assistant Professor, NYU School of Medicine

Luciano Sposato, MD, MBA
Head Stroke Program, LHSC
Professor of Neurology, CNS Dept.
K. & Dr. Henry Barnett Chair in Stroke Research
Schulich School of Medicine & Dentistry, Western U
Director, Heart & Brain Lab, London, ON, Canada

Toby Trujillo, PharmD, BCPS
Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Clinical Specialist, Anticoagulation/Cardiology
University of Colorado Hospital
Co-chair, Anticoagulation Subcommittee and Stewardship Program
UC Health

Scott Bernstein, MD
Cardiac Arrhythmia Management Service
Leon H. Charney Division of Cardiology
New York University Langone Medical Center

Gregory Marcus, MD, MAS
Professor of Medicine in Residence
Associate Chief of Cardiology for Research
Endowed Professor of Atrial Fibrillation Research
University of California, San Francisco

ORIGINAL RELEASE DATE: 06/19/2024
TERMINATION DATE: 06/18/2027
LAST REVIEW DATE: April 2024
ACCREDITATION TERMS: Joint Accreditation: 06/19/2024 – 06/18/2027

In support of improving patient care, this activity has been planned and implemented by The American Heart Association. The American Heart Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement - Physicians
The American Heart Association designates this activity for a maximum of 1.00 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CE activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

AAPA Credit Acceptance Statement – Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.00 hours of Category I credit for completing this program.

AANP Credit Acceptance Statement – Nurse Practitioners
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

ANCC Credit Designation Statement - Nurses
The maximum number of hours awarded for this CE activity is 1.00 contact hours.

ACPE Credit Designation Statement – Pharmacists
ACPE Credit: 1.00 Contact Hours.  Universal Program Number: JA0000134-0000-24-049-H04-P

Disclosures
All persons in a position to control educational content of a CE activity provided by the American Heart Association must disclose to the audience all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The presence or absence of all financial relationships will be disclosed to the audience in activity materials. All unlabeled/unapproved uses of drugs or devices discussed will also be disclosed to the audience. All relevant financial relationships have been mitigated prior to the commencement of the activity.  

Medium
This activity is an internet-based activity.

Contact Information
For customer support contact 1-877-340-9899 (Monday-Friday, 8:00 am to 6:00 pm Central Standard Time) or email education.help@email.education.heart.org.

Policy on Privacy and Confidentiality
Please see the privacy link at the bottom of the AHA Professional Education Hub.

Copyright Information
Please see the link at the bottom of the AHA Professional Education Hub.

Commercial Support
This activity is supported by an independent medical education grant by Bristol Myers Squibb.